Palisade BioPALI

13F holders, Q3 2025 (September 30)
12holders +1
2new positions
1sold out
$0.86avg. 13F price*

At the end of Q3 2025, 12 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Two Sigma Securities, LLC ($25K), Geode Capital Management, LLC ($23K) and UBS Group AG ($17K).

Company
Palisade Bio Inc.
CUSIP
696389402
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q2 2024: 8Q2 2024Q3 2024: 9Q3 2024Q4 2024: 10Q4 2024Q1 2025: 13Q1 2025Q2 2025: 11Q2 2025Q3 2025: 12Q3 2025Q4 2025: 86Q4 2025Q1 2026: 96Q1 2026Q2 2026: 124Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions2$2K
Exits1$680

All 13F filers, Q2 2025 → Q3 2025: 49,234 shares bought and 14,252 shares sold, net +34,982 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

Two Sigma Securities, LLC 0.00% Add +84.1% 29,406 $25K
Geode Capital Management, LLC 0.00% Add +7.6% 26,620 $23K
UBS Group AG 0.00% Add +5747.3% 19,413 $17K
XTX Topco Ltd 0.00% Reduce -48.5% 14,085 $12K
NFSG Corp 0.00% Add +23.8% 13,000 $11K
Morgan Stanley 0.00% Add +123014.3% 8,618 $7K
Tower Research Capital LLC (TRC) 0.00% Add +18.1% 5,396 $5K
Citigroup Inc. 0.00% New 2,347 $2K
Rockefeller Capital Management L.P. 0.00% New 500 $430
Federation des caisses Desjardins du Quebec 0.00% No change 100 $86
Bank of America Corp. 0.00% Add +91.1% 86 $73
Wells Fargo & Company 0.00% No change 21 $18

"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.